Portside Wealth Group, LLC Charles River Laboratories International, Inc. Transaction History
Portside Wealth Group, LLC
- $578 Billion
- Q4 2024
A detailed history of Portside Wealth Group, LLC transactions in Charles River Laboratories International, Inc. stock. As of the latest transaction made, Portside Wealth Group, LLC holds 1,096 shares of CRL stock, worth $182,878. This represents 0.04% of its overall portfolio holdings.
Number of Shares
1,096
Previous 1,104
0.72%
Holding current value
$182,878
Previous $217 Million
0.72%
% of portfolio
0.04%
Previous 0.04%
Shares
8 transactions
Others Institutions Holding CRL
# of Institutions
694Shares Held
52MCall Options Held
259KPut Options Held
463K-
Vanguard Group Inc Valley Forge, PA6.1MShares$1.02 Billion0.02% of portfolio
-
Black Rock Inc. New York, NY5.09MShares$849 Million0.02% of portfolio
-
Wellington Management Group LLP Boston, MA3.74MShares$624 Million0.13% of portfolio
-
State Street Corp Boston, MA2.13MShares$355 Million0.02% of portfolio
-
Kayne Anderson Rudnick Investment Management LLC Los Angeles, CA1.94MShares$324 Million0.87% of portfolio
About CHARLES RIVER LABORATORIES INTERNATIONAL, INC.
- Ticker CRL
- Exchange NYSE
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 50,863,300
- Market Cap $8.49B
- Description
- Charles River Laboratories International, Inc., a non-clinical contract research organization, provides drug discovery, non-clinical development, and safety testing services in the United States, Europe, Canada, the Asia Pacific, and internationally. It operates through three segments: Research Models and Services (RMS), Discovery and Safety Ass...